other glp 1 agonists Frontiers Best Med #2: GLP-1 Receptor
Description
This builds on his work to understand 'how circulating GLP-1 can produce multiple actions, both directly and indirectly, on multiple organs' which he has pursued for many years with colleagues (McLean, Wong, Campbell)
If a medication tier is not delivering expected results, providers can adjust the prescription when medically appropriate
Consumers may start with Lane 1 changes, then graduate to Lane 2 supplements if they need an extra push, and only consider Lane 3 drugs if those dont suffice
Vitastir has their business model down to a smooth science
I.MalarD
Alzheimers Dement (2020) 16(9):131229
